These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9810769)

  • 21. Homozygosity in the major histocompatibility complex region influences natural killer cell activity in man.
    Dubey DP; Yunis I; Leslie CA; Mehta C; Yunis EJ
    Eur J Immunol; 1987 Jan; 17(1):61-6. PubMed ID: 3816935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors.
    Hoare HL; Sullivan LC; Clements CS; Ely LK; Beddoe T; Henderson KN; Lin J; Reid HH; Brooks AG; Rossjohn J
    J Mol Biol; 2008 Apr; 377(5):1297-303. PubMed ID: 18339401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphism and evolution of HLA class I and II genes and molecules.
    Little AM; Parham P
    Rev Immunogenet; 1999; 1(1):105-23. PubMed ID: 11256568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Human histocompatibility HLA system. Considerations in the light of current concepts. VIII. Polymorphism of HLA-related MIC system].
    Kedzierska A; Turowski G
    Przegl Lek; 2001; 58(12):1076-8. PubMed ID: 12041026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA-G polymorphism and evolution.
    Arnaiz-Villena A; Martinez-Laso J; Serrano-Vela JI; Reguera R; Moscoso J
    Tissue Antigens; 2007 Apr; 69 Suppl 1():156-9. PubMed ID: 17445193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-G and immune tolerance in pregnancy.
    Hunt JS; Petroff MG; McIntire RH; Ober C
    FASEB J; 2005 May; 19(7):681-93. PubMed ID: 15857883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
    Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
    Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity.
    Sullivan LC; Clements CS; Rossjohn J; Brooks AG
    Tissue Antigens; 2008 Nov; 72(5):415-24. PubMed ID: 18946929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microsatellite DNA markers from HLA region (D6S105, D6S265 and TNFa) in autochthonous Basques from Northern Navarre (Spain).
    Peña JA; Calderon R; Perez-Miranda A; Vidales C; Dugoujon JM; Carrion M; Crouau-Roy B
    Ann Hum Biol; 2002; 29(2):176-91. PubMed ID: 11874622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
    Lilienfeld BG; Crew MD; Forte P; Baumann BC; Seebach JD
    Xenotransplantation; 2007 Mar; 14(2):126-34. PubMed ID: 17381687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
    Wang D; Quan Y; Yan Q; Morales JE; Wetsel RA
    Stem Cells Transl Med; 2015 Oct; 4(10):1234-45. PubMed ID: 26285657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Role of Human Leukocyte Antigen in Health and Disease.
    Mosaad YM
    Scand J Immunol; 2015 Oct; 82(4):283-306. PubMed ID: 26099424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alloreactive natural killer cells in the rat: complex genetics of major histocompatibility complex control.
    Naper C; Vaage JT; Lambracht D; Løvik G; Butcher GW; Wonigeit K; Rolstad B
    Eur J Immunol; 1995 May; 25(5):1249-56. PubMed ID: 7774627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Histocompatibility HLA system of man. Considerations in the light of current concepts. VI. HLA-G antigen polymorphism].
    Kedzierska A; Turowski G
    Przegl Lek; 2001; 58(10):936-9. PubMed ID: 11957823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The HLA gene complex].
    Mayr WR
    Infusionsther Transfusionsmed; 1994 Jun; 21(3):185-91. PubMed ID: 7919906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA-E regulates NKG2C+ natural killer cell function through presentation of a restricted peptide repertoire.
    Lauterbach N; Wieten L; Popeijus HE; Voorter CE; Tilanus MG
    Hum Immunol; 2015 Aug; 76(8):578-86. PubMed ID: 26382247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
    Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA and KIR polymorphisms affect NK-cell anti-tumor activity.
    Passweg JR; Huard B; Tiercy JM; Roosnek E
    Trends Immunol; 2007 Oct; 28(10):437-41. PubMed ID: 17825623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of HLA class I antigen deficiency related to a TAP2 gene mutation with familial bronchiectasis.
    Donato L; de la Salle H; Hanau D; Tongio MM; Oswald M; Vandevenne A; Geisert J
    J Pediatr; 1995 Dec; 127(6):895-900. PubMed ID: 8523185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current perspectives on the intensity of natural selection of MHC loci.
    Yasukochi Y; Satta Y
    Immunogenetics; 2013 Jun; 65(6):479-83. PubMed ID: 23549729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.